Article Details

FDA Approves TEZSPIRE™ (tezepelumab-ekko), AstraZeneca and Amgen's First-in ... - BioSpace

Retrieved on: 2021-12-22 17:20:55

Tags for this article:

Click the tags to see associated articles and topics

FDA Approves TEZSPIRE™ (tezepelumab-ekko), AstraZeneca and Amgen's First-in ... - BioSpace. View article details on hiswai:

Excerpt

FDA Approves TEZSPIRE™ (tezepelumab-ekko), AstraZeneca and Amgen's First-in-Class Treatment for Severe Asthma - read this article along with other ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up